The Treatment Advocacy Center
The Treatment Advocacy Center (TAC) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment for people with severe mental illness including schizophrenia and bipolar disorder. We do not accept funding from the pharmaceutical industry. TAC promotes laws, policies and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder. The Stanley Medical Research Institute is a fully integrated supporting organization to the Treatment Advocacy Center.
Current Research Weekly Article
“Shared decision-making, a clinical care approach where clinicians and patients discuss evidence together and make concerted choices about appropriate treatments, is a principle of quality healthcare that has become more prevalent in clinical guidelines for mental healthcare. However, in practice, caregiver or family member involvement in mental healthcare decision-making is rarely explicitly addressed. A piece published in Psychiatric Services this month argues that family caregivers, in addition to patients themselves, should be involved in shared decision-making and are an integral component of any clinical practice. The authors summarize evidence demonstrating the benefits of caregiver involvement for improving clinical decision-making and outcomes for individuals with mental illness. Drawing conclusions from the evidence, they suggest that more work is needed to facilitate caregiver participation in mental healthcare decisions.”
Read more from this article “Promoting Caregiver Involvement in Treatment of People with Severe Mental Illness” here
Selected 2019 Articles
Selected 2018 Articles